Development of a clinical scoring system for assessment of immunosuppression in patients with tuberculosis and HIV infection without access to CD4 cell testing - results from a cross-sectional study in Ethiopia [Elektronisk resurs]
-
Skogmar, Sten (författare)
-
Balcha, Taye T. (författare)
-
Jemal, Zelalem H. (författare)
-
Bjork, Jonas (författare)
-
Deressa, Wakgari (författare)
-
Schön, Thomas (författare)
-
Bjorkman, Per (författare)
-
- Linköpings universitet Institutionen för klinisk och experimentell medicin (utgivare)
-
-
Alternativt namn: IKE
-
Alternativt namn: Linköping University. Department of Clinical and Experimental Medicine
-
Alternativt namn: Linköping University. Faculty of Health Sciences. Department of Clinical and Experimental Medicine
-
Linköpings universitet Hälsouniversitetet (utgivare)
- Co-Action Publishing: Creative Commons Attribution / Co-Action Publishing 2014
- Engelska.
-
Ingår i: Global Health Action. - 1654-9716. ; 7:23105
-
Läs hela texten
-
Läs hela texten
-
Läs hela texten
Sammanfattning
Ämnesord
Stäng
- Background: Currently, antiretroviral therapy (ART) is recommended for all HIV-positive patients with tuberculosis (TB). The timing of ART during the course of anti-TB treatment is based on CD4 cell counts. Access to CD4 cell testing is not universally available; this constitutes an obstacle for the provision of ART in low-income countries. Objective: To determine clinical variables associated with HIV co-infection in TB patients and to identify correlations between clinical variables and CD4 cell strata in HIV/TB co-infected subjects, with the aim of developing a clinical scoring system for the assessment of immunosuppression. Design: Cross-sectional study of adults with TB (with and without HIV co-infection) recruited in Ethiopian outpatient clinics. Clinical variables potentially associated with immunosuppression were recorded using a structured questionnaire, and they were correlated to CD4 cell strata used to determine timing of ART initiation. Variables found to be significant in multivariate analysis were used to construct a scoring system. Results: Among 1,116 participants, the following findings were significantly more frequent in 307 HIV-positive patients compared to 809 HIV-negative subjects: diarrhea, odynophagia, conjunctival pallor, herpes zoster, oral candidiasis, skin rash, and mid-upper arm circumference (MUAC) less than20 cm. Among HIV-positive patients, conjunctival pallor, MUAC less than20 cm, dyspnea, oral hairy leukoplakia (OHL), oral candidiasis, and gingivitis were significantly associated with less than350 CD4 cells/mm(3). A scoring system based on these variables had a negative predictive value of 87% for excluding subjects with CD4 cell counts less than100 cells/mm(3); however, the positive predictive value for identifying such individuals was low (47%). Conclusions: Clinical variables correlate with CD4 cell strata in HIV-positive patients with TB. The clinical scoring system had adequate negative predictive value for excluding severe immunosuppression. Clinical scoring systems could be of use to categorize TB/HIV co-infected patients with regard to the timing of ART initiation in settings with limited access to laboratory facilities.
Ämnesord
- Medical and Health Sciences (hsv)
- Basic Medicine (hsv)
- Microbiology in the medical area (hsv)
- Medicin och hälsovetenskap (hsv)
- Medicinska grundvetenskaper (hsv)
- Mikrobiologi inom det medicinska området (hsv)
- Clinical Medicine (hsv)
- Klinisk medicin (hsv)
- MEDICINE (svep)
- MEDICIN (svep)
Indexterm och SAB-rubrik
- HIV; tuberculosis; Ethiopia; scoring system; CD4 cell; timing of ART
Inställningar
Hjälp
Beståndsinformation saknas